Slingshot members are tracking this event:

Halozyme Therapeutics (HALO) to release HALO-202 study data on combination of PEG PH20 and gemcitabime in treating pancreatic cancer in 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
HALO Community voting in process